C4 Therapeutics, Inc. (CCCC)
3.10
+0.15
(+5.08%)
USD |
NASDAQ |
Nov 06, 16:00
3.09
-0.01
(-0.32%)
After-Hours: 20:00
C4 Therapeutics Price : 3.10 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2.96 | 3.21 | 2.951 | 3.10 | 4.326M |
| Nov 05, 2026 | 3.08 | 3.22 | 2.905 | 2.95 | 3.684M |
| Nov 04, 2026 | 3.36 | 3.385 | 3.02 | 3.12 | 1.972M |
| Nov 03, 2026 | 3.27 | 3.42 | 3.17 | 3.21 | 1.585M |
| Nov 02, 2026 | 3.36 | 3.41 | 3.16 | 3.21 | 2.862M |
| Oct 30, 2026 | 3.23 | 3.38 | 3.21 | 3.37 | 2.354M |
| Oct 29, 2026 | 3.41 | 3.44 | 3.20 | 3.30 | 2.715M |
| Oct 28, 2026 | 3.25 | 3.53 | 3.23 | 3.395 | 4.111M |
| Oct 27, 2026 | 2.99 | 3.24 | 2.950 | 3.21 | 4.120M |
| Oct 26, 2026 | 3.07 | 3.07 | 2.94 | 2.98 | 3.179M |
| Oct 23, 2026 | 3.16 | 3.17 | 3.02 | 3.06 | 4.742M |
| Oct 22, 2026 | 3.13 | 3.25 | 3.12 | 3.18 | 1.693M |
| Oct 21, 2026 | 3.15 | 3.22 | 3.10 | 3.17 | 2.190M |
| Oct 20, 2026 | 2.86 | 3.20 | 2.855 | 3.16 | 3.689M |
| Oct 19, 2026 | 2.80 | 2.94 | 2.80 | 2.89 | 3.113M |
| Oct 16, 2026 | 2.78 | 2.81 | 2.695 | 2.765 | 2.359M |
| Oct 15, 2026 | 2.64 | 2.846 | 2.60 | 2.78 | 3.275M |
| Oct 14, 2026 | 2.72 | 2.795 | 2.59 | 2.61 | 3.100M |
| Oct 13, 2026 | 3.04 | 3.06 | 2.75 | 2.78 | 3.821M |
| Oct 12, 2026 | 3.16 | 3.30 | 3.05 | 3.06 | 1.500M |
| Oct 09, 2026 | 3.00 | 3.190 | 2.95 | 3.16 | 2.507M |
| Oct 08, 2026 | 2.80 | 2.88 | 2.721 | 2.85 | 2.828M |
| Oct 07, 2026 | 2.85 | 2.95 | 2.82 | 2.82 | 2.268M |
| Oct 06, 2026 | 3.02 | 3.03 | 2.79 | 2.88 | 2.114M |
| Oct 05, 2026 | 3.01 | 3.10 | 2.95 | 2.99 | 1.464M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 11.35 |
| Kymera Therapeutics, Inc. | 131.73 |
| NKGen Biotech, Inc. | 0.011 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
| Oncolytics Biotech, Inc. | 0.4394 |
Price Related Metrics
| PS Ratio | 12.24 |
| Price to Book Value | 1.784 |
| Earnings Yield | -23.10% |
| Market Cap | 381.01M |